Optimus becomes the First Company to Conclude Study of Molnupiravir Phase 3 Clinical Trial with Promising Results
Optimus Group has announced the successful completion of the much-awaited Molnupiravir Oral…
Optimus Group has announced the successful completion of the much-awaited Molnupiravir Oral…
Sign in to your account